| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/JVI.76.21.10579-10587.2002 |
| P8608 | Fatcat ID | release_m2gicif2z5cr3aknfuby2vbdcy |
| P932 | PMC publication ID | 136632 |
| P698 | PubMed publication ID | 12368300 |
| P5875 | ResearchGate publication ID | 11091754 |
| P50 | author | Andrew P Rice | Q55277928 |
| P2093 | author name string | Christine H Herrmann | |
| Li-Ying Liou | |||
| P2860 | cites work | Identification of multiple cyclin subunits of human P-TEFb | Q24317025 |
| CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA | Q24550765 | ||
| Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter | Q24552532 | ||
| Coupling of cell division to cell growth by translational control of the G1 cyclin CLN3 in yeast | Q24606696 | ||
| Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor | Q24676286 | ||
| The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function | Q24682531 | ||
| Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol | Q24805832 | ||
| Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g | Q26778365 | ||
| 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes | Q28116607 | ||
| The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription | Q28206012 | ||
| The challenge of viral reservoirs in HIV-1 infection | Q28216956 | ||
| A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA | Q28263974 | ||
| Upregulation of cyclin T1/CDK9 complexes during T cell activation | Q28292597 | ||
| P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro | Q28379179 | ||
| Enforced Expression of Bcl-2 in Monocytes Rescues Macrophages and Partially Reverses Osteopetrosis in op/op Mice | Q28593712 | ||
| TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines | Q28647556 | ||
| Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro | Q29614788 | ||
| PEST sequences and regulation by proteolysis | Q29616394 | ||
| P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II | Q29620167 | ||
| Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages | Q33547151 | ||
| Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides. | Q33669300 | ||
| HIV-1 Tat: coping with negative elongation factors | Q33711447 | ||
| Tackling Tat. | Q33767907 | ||
| Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation | Q33774044 | ||
| CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection | Q33782193 | ||
| Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines | Q33786066 | ||
| Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells | Q33836069 | ||
| Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines | Q33849629 | ||
| The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions. | Q33940905 | ||
| Phosphorylation in transcription: the CTD and more | Q34093159 | ||
| Infection of monocyte/macrophages by human T lymphotropic virus type III. | Q34579117 | ||
| Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T | Q34987620 | ||
| The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein | Q35211232 | ||
| Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1) | Q35596389 | ||
| Origin and turnover of monocytes and macrophages | Q38600410 | ||
| Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism | Q39446082 | ||
| Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1. | Q39589026 | ||
| Binding of Tat to TAR and recruitment of positive transcription elongation factor b occur independently in bovine immunodeficiency virus | Q39591738 | ||
| Viral transactivators specifically target distinct cellular protein kinases that phosphorylate the RNA polymerase II C-terminal domain | Q39715447 | ||
| The immunopathogenesis of equine infectious anemia virus | Q40692664 | ||
| Visualization of in vivo direct interaction between HIV-1 TAT and human cyclin T1 in specific subcellular compartments by fluorescence resonance energy transfer | Q40786197 | ||
| Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. | Q40990135 | ||
| The leukocyte integrin gene CD11c is transcriptionally regulated during monocyte differentiation | Q41353454 | ||
| In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). | Q45836762 | ||
| Isolation and characterization of the human cyclin T1 promoter | Q47844049 | ||
| Macrophages as a source of HIV during opportunistic infections | Q73427586 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| P304 | page(s) | 10579-10587 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function | |
| P478 | volume | 76 |
| Q35746236 | Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, Indirubin-3'-monoxime |
| Q37033370 | Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29. |
| Q33347964 | Cell-type-specific proteome and interactome: using HIV-1 Tat as a test case |
| Q57795262 | Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors |
| Q34667185 | Cyclin L2 is a critical HIV dependency factor in macrophages that controls SAMHD1 abundance |
| Q33367106 | Cyclin T1-dependent genes in activated CD4 T and macrophage cell lines appear enriched in HIV-1 co-factors |
| Q28565260 | Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes |
| Q38995028 | Cyclin-dependent kinases as therapeutic targets for HIV-1 infection. |
| Q40642204 | Differential activation of Tat variants in mitogen-stimulated cells: implications for HIV-1 postintegration latency |
| Q64120094 | Entry of Polarized Effector Cells into Quiescence Forces HIV Latency |
| Q37229398 | HIV interactions with monocytes and dendritic cells: viral latency and reservoirs |
| Q37974218 | HIV latency |
| Q33846376 | Host hindrance to HIV-1 replication in monocytes and macrophages |
| Q36330062 | Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication |
| Q41039158 | Human immunodeficiency virus type 1 infection induces cyclin T1 expression in macrophages. |
| Q41274276 | Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function |
| Q38518336 | Induction of the HIV-1 Tat co-factor cyclin T1 during monocyte differentiation is required for the regulated expression of a large portion of cellular mRNAs. |
| Q36850296 | Inhibition of HIV-1 transcription and replication by a newly identified cyclin T1 splice variant. |
| Q24298519 | Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA |
| Q26781552 | Interaction of drugs of abuse and microRNA with HIV: a brief review |
| Q79745144 | Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis |
| Q33972021 | Limited redundancy in genes regulated by Cyclin T2 and Cyclin T1. |
| Q38212042 | Making a Short Story Long: Regulation of P-TEFb and HIV-1 Transcriptional Elongation in CD4+ T Lymphocytes and Macrophages. |
| Q34983626 | Mammalian MicroRNAs: Post-Transcriptional Gene Regulation in RNA Virus Infection and Therapeutic Applications. |
| Q36404157 | MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes. |
| Q35764627 | MicroRNA: implications in HIV, a brief overview |
| Q33602605 | Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat |
| Q35868607 | Network-based gene expression biomarkers for cold and heat patterns of rheumatoid arthritis in traditional chinese medicine |
| Q89782162 | P-TEFb as A Promising Therapeutic Target |
| Q36305691 | PKC phosphorylates HEXIM1 and regulates P-TEFb activity. |
| Q38008733 | Perspective of cyclin-dependent kinase 9 (CDK9) as a drug target. |
| Q33373237 | Phosphatase PPM1A regulates phosphorylation of Thr-186 in the Cdk9 T-loop |
| Q46675052 | Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA. |
| Q40073989 | Potent and selective inhibition of Tat-dependent HIV-1 replication in chronically infected cells by a novel naphthalene derivative JTK-101. |
| Q35942658 | Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors. |
| Q36887625 | Regulation of HIV-1 latency by T-cell activation. |
| Q28391037 | Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj |
| Q35196505 | Role of myeloid cells in HIV-1-host interplay |
| Q37631411 | Role of noncoding RNAs in the regulation of P-TEFb availability and enzymatic activity |
| Q33922921 | T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes. |
| Q34647848 | Tax interacts with P-TEFb in a novel manner to stimulate human T-lymphotropic virus type 1 transcription |
| Q44720095 | Techniques to analyze the HIV-1 Tat and TAR RNA-dependent recruitment and activation of the cyclin T1: CDK9 (P-TEFb) transcription elongation factor. |
| Q40135003 | The HIV-1 Tat protein: mechanism of action and target for HIV-1 cure strategies. |
| Q92188718 | The Role of Macrophages in HIV-1 Persistence and Pathogenesis |
| Q37145340 | Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes |
| Q33400321 | miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1 |
Search more.